These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 19712129

  • 1. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression.
    Ishii A, Suzuki M, Satomi K, Kobayashi H, Sakashita S, Kano J, Pei Y, Minami Y, Ishikawa S, Noguchi M.
    Pathol Int; 2009 Sep; 59(9):623-30. PubMed ID: 19712129
    [Abstract] [Full Text] [Related]

  • 2. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas.
    Komatsu K, Andoh A, Ishiguro S, Suzuki N, Hunai H, Kobune-Fujiwara Y, Kameyama M, Miyoshi J, Akedo H, Nakamura H.
    Clin Cancer Res; 2000 Jan; 6(1):172-7. PubMed ID: 10656447
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 6. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
    Yu M, Zheng H, Tsuneyama K, Takahashi H, Nomoto K, Xu H, Takano Y.
    Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
    [Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
    Sarkaria IS, Zakowski MF, Pham D, Hezel M, Ebright MI, Chuai S, Venkatraman ES, Kris MG, Rusch VW, Singh B.
    Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
    [Abstract] [Full Text] [Related]

  • 8. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
    Niki T, Iba S, Yamada T, Matsuno Y, Enholm B, Hirohashi S.
    J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
    [Abstract] [Full Text] [Related]

  • 9. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma.
    Alì G, Donati V, Loggini B, Servadio A, Dell'Omodarme M, Prati MC, Camacci T, Lucchi M, Melfi F, Mussi A, Fontanini G.
    Hum Pathol; 2008 Oct; 39(10):1465-73. PubMed ID: 18620727
    [Abstract] [Full Text] [Related]

  • 10. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM, MacKenzie SJ, Ramasami S, Murray GI, Fyfe N, Chapman AD, Nicolson MC, King G.
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples.
    Ohuchida K, Mizumoto K, Yu J, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M.
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):649-54. PubMed ID: 17416753
    [Abstract] [Full Text] [Related]

  • 13. Upregulated expression of S100A6 in human gastric cancer.
    Yang YQ, Zhang LJ, Dong H, Jiang CL, Zhu ZG, Wu JX, Wu YL, Han JS, Xiao HS, Gao HJ, Zhang QH.
    J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
    [Abstract] [Full Text] [Related]

  • 14. MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications.
    Hashimoto K, Araki K, Osaki M, Nakamura H, Tomita K, Shimizu E, Ito H.
    Pathobiology; 2004 Nov; 71(4):193-200. PubMed ID: 15263808
    [Abstract] [Full Text] [Related]

  • 15. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
    Kamimura A, Kamachi M, Nishihira J, Ogura S, Isobe H, Dosaka-Akita H, Ogata A, Shindoh M, Ohbuchi T, Kawakami Y.
    Cancer; 2000 Jul 15; 89(2):334-41. PubMed ID: 10918163
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
    Goto A, Niki T, Moriyama S, Funata N, Moriyama H, Nishimura Y, Tsuchida R, Kato JY, Fukayama M.
    Pathol Int; 2004 Sep 15; 54(9):675-81. PubMed ID: 15363035
    [Abstract] [Full Text] [Related]

  • 18. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.
    Jian Z, Tomizawa Y, Yanagitani N, Iijima H, Sano T, Nakajima T.
    Pathol Int; 2005 Oct 15; 55(10):619-25. PubMed ID: 16185291
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.
    Rosen DG, Yang G, Cai KQ, Bast RC, Gershenson DM, Silva EG, Liu J.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):632-7. PubMed ID: 15701850
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.